APOE ε4 carriage associates with improved myocardial performance from adolescence to older age.
Apolipoprotein ε4
Cardiovascular disease
Myocardial contraction fraction
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
11
05
2023
accepted:
21
02
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
epublish
Résumé
Although APOE ε4 allele carriage confers a risk for coronary artery disease, its persistence in humans might be explained by certain survival advantages (antagonistic pleiotropy). Combining data from ~ 37,000 persons from three older age British cohorts (1946 National Survey of Health and Development [NSHD], Southall and Brent Revised [SABRE], and UK Biobank) and one younger age cohort (Avon Longitudinal Study of Parents and Children [ALSPAC]), we explored whether APOE ε4 carriage associates with beneficial or unfavorable left ventricular (LV) structural and functional metrics by echocardiography and cardiovascular magnetic resonance (CMR). Compared to the non-APOE ε4 group, APOE ε4 carriers had similar cardiac phenotypes in terms of LV ejection fraction, E/e', posterior wall and interventricular septal thickness, and LV mass. However, they had improved myocardial performance resulting in greater LV stroke volume generation per 1 mL of myocardium (higher myocardial contraction fraction). In NSHD (n = 1467) and SABRE (n = 1187), ε4 carriers had a 4% higher MCF (95% CI 1-7%, p = 0.016) using echocardiography. Using CMR data, in UK Biobank (n = 32,972), ε4 carriers had a 1% higher MCF 95% (CI 0-1%, p = 0.020) with a dose-response relationship based on the number of ε4 alleles. In addition, UK Biobank ε4 carriers also had more favorable radial and longitudinal strain rates compared to non APOE ε4 carriers. In ALSPAC (n = 1397), APOE ε4 carriers aged < 24 years had a 2% higher MCF (95% CI 0-5%, p = 0.059). By triangulating results in four independent cohorts, across imaging modalities (echocardiography and CMR), and in ~ 37,000 individuals, our results point towards an association between ε4 carriage and improved cardiac performance in terms of LV MCF. This potentially favorable cardiac phenotype adds to the growing number of reported survival advantages attributed to the pleiotropic effects APOE ε4 carriage that might collectively explain its persistence in human populations.
Sections du résumé
BACKGROUND
BACKGROUND
Although APOE ε4 allele carriage confers a risk for coronary artery disease, its persistence in humans might be explained by certain survival advantages (antagonistic pleiotropy).
METHODS
METHODS
Combining data from ~ 37,000 persons from three older age British cohorts (1946 National Survey of Health and Development [NSHD], Southall and Brent Revised [SABRE], and UK Biobank) and one younger age cohort (Avon Longitudinal Study of Parents and Children [ALSPAC]), we explored whether APOE ε4 carriage associates with beneficial or unfavorable left ventricular (LV) structural and functional metrics by echocardiography and cardiovascular magnetic resonance (CMR).
RESULTS
RESULTS
Compared to the non-APOE ε4 group, APOE ε4 carriers had similar cardiac phenotypes in terms of LV ejection fraction, E/e', posterior wall and interventricular septal thickness, and LV mass. However, they had improved myocardial performance resulting in greater LV stroke volume generation per 1 mL of myocardium (higher myocardial contraction fraction). In NSHD (n = 1467) and SABRE (n = 1187), ε4 carriers had a 4% higher MCF (95% CI 1-7%, p = 0.016) using echocardiography. Using CMR data, in UK Biobank (n = 32,972), ε4 carriers had a 1% higher MCF 95% (CI 0-1%, p = 0.020) with a dose-response relationship based on the number of ε4 alleles. In addition, UK Biobank ε4 carriers also had more favorable radial and longitudinal strain rates compared to non APOE ε4 carriers. In ALSPAC (n = 1397), APOE ε4 carriers aged < 24 years had a 2% higher MCF (95% CI 0-5%, p = 0.059).
CONCLUSIONS
CONCLUSIONS
By triangulating results in four independent cohorts, across imaging modalities (echocardiography and CMR), and in ~ 37,000 individuals, our results point towards an association between ε4 carriage and improved cardiac performance in terms of LV MCF. This potentially favorable cardiac phenotype adds to the growing number of reported survival advantages attributed to the pleiotropic effects APOE ε4 carriage that might collectively explain its persistence in human populations.
Identifiants
pubmed: 38509472
doi: 10.1186/s12872-024-03808-z
pii: 10.1186/s12872-024-03808-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
172Informations de copyright
© 2024. The Author(s).
Références
Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (American Association for the Advancement of Science). 1988;240:622–30. https://doi.org/10.1126/science.3283935 .
doi: 10.1126/science.3283935
Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501–18. https://doi.org/10.1038/s41582-019-0228-7 .
doi: 10.1038/s41582-019-0228-7
pubmed: 31367008
pmcid: 7055192
Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang L-S, Romero K, Arneric SP, Redolfi A, et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a Meta-analysis. JAMA neurology. 2017;74:1178–89. https://doi.org/10.1001/jamaneurol.2017.2188 .
doi: 10.1001/jamaneurol.2017.2188
pubmed: 28846757
pmcid: 5759346
Skoog I, Horder H, Frandin K, Johansson L, Ostling S, Blennow K, Zetterberg H, Zettergren A. Association between APOE genotype and change in physical function in a population-based Swedish cohort of older individuals followed over four years; 2016.
doi: 10.3389/fnagi.2016.00225
Nao J, Sun H, Wang Q, Ma S, Zhang S, Dong X, Ma Y, Wang X, Zheng D. Adverse effects of the apolipoprotein E ε4 allele on episodic memory, task switching and gray matter volume in healthy young adults. Front Hum Neurosci. 2017;11:346–6. https://doi.org/10.3389/fnhum.2017.00346 .
doi: 10.3389/fnhum.2017.00346
pubmed: 28706481
pmcid: 5489690
Tuminello ER, Han SD. The Apolipoprotein E antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis. 2011;2011:726197–12. https://doi.org/10.4061/2011/726197 .
doi: 10.4061/2011/726197
pubmed: 21423560
pmcid: 3056453
Smith CJ, Ashford JW, Perfetti TA. Putative survival advantages in Young Apolipoprotein ɛ4 carriers are associated with increased neural stress. J Alzheimers Dis. 2019;68:885–923. https://doi.org/10.3233/JAD-181089 .
doi: 10.3233/JAD-181089
pubmed: 30814349
pmcid: 6484250
Jasienska G, Ellison PT, Galbarczyk A, Jasienski M, Kalemba-Drozdz M, Kapiszewska M, Nenko I, Thune I, Ziomkiewicz A. Apolipoprotein E (ApoE) polymorphism is related to differences in potential fertility in women: a case of antagonistic pleiotropy? Proc R Soc B Biol Sci. 2015;282:20142395–5. https://doi.org/10.1098/rspb.2014.2395 .
doi: 10.1098/rspb.2014.2395
Lumsden AL, Mulugeta A, Zhou A, Hyppönen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK biobank. EBioMedicine. 2020;59:102954–4. https://doi.org/10.1016/j.ebiom.2020.102954 .
doi: 10.1016/j.ebiom.2020.102954
pubmed: 32818802
pmcid: 7452404
Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional—executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences - PNAS. 2010;107:10256–61. https://doi.org/10.1073/pnas.1001412107 .
doi: 10.1073/pnas.1001412107
Zhao QR, Lei YY, Li J, Jiang N, Shi JP. Association between apolipoprotein E polymorphisms and premature coronary artery disease: a meta-analysis. Clin Chem Lab Med. 2017;55:284–98. https://doi.org/10.1515/cclm-2016-0145 .
doi: 10.1515/cclm-2016-0145
pubmed: 27394044
Shi J, Liu Y, Liu Y, Li Y, Qiu S, Bai Y, Gu Y, Luo J, Cui H, Li Y, et al. Association between ApoE polymorphism and hypertension: a meta-analysis of 28 studies including 5898 cases and 7518 controls. GENE. 2018;675:197–207. https://doi.org/10.1016/j.gene.2018.06.097 .
doi: 10.1016/j.gene.2018.06.097
pubmed: 30180966
Chen DW, Shi JK, Li Y, Yang Y, Ren SP. Association between ApoE polymorphism and type 2 diabetes: a Meta-analysis of 59 studies. Biomed Environ Sci. 2019;32:823–38. https://doi.org/10.3967/bes2019.104 .
doi: 10.3967/bes2019.104
pubmed: 31910940
Khan TA, Shah T, Prieto D, Zhang W, Price J, Fowkes GR, Cooper J, Talmud PJ, Humphries SE, Sundstrom J, et al. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals. Int J Epidemiol. 2013;42:475–92. https://doi.org/10.1093/ije/dyt034 .
doi: 10.1093/ije/dyt034
pubmed: 23569189
pmcid: 3619955
Mueller K, Thiel F, Beutner F, Teren A, Frisch S, Ballarini T, Möller HE, Ihle K, Thiery J, Schuler G, et al. Brain damage with heart failure: cardiac biomarker alterations and gray matter decline. Circ Res. 2020;126:750–64. https://doi.org/10.1161/CIRCRESAHA.119.315813 .
doi: 10.1161/CIRCRESAHA.119.315813
pubmed: 31969053
pmcid: 7077969
Golding J, Pembrey M, Jones J. ALSPAC - the Avon longitudinal study of parents and children I. Study methodology Paediatric and perinatal epidemiology. 2001;15:74–87. https://doi.org/10.1046/j.1365-3016.2001.00325.x .
doi: 10.1046/j.1365-3016.2001.00325.x
pubmed: 11237119
Kuh D, Pierce M, Adams J, Deanfield J, Ekelund U, Friberg P, Ghosh AK, Harwood N, Hughes A, Macfarlane PW, et al. Cohort profile: updating the cohort profile for the MRC National Survey of health and development: a new clinic-based data collection for ageing research. Int J Epidemiol. 2011;40(1):e1–9.
doi: 10.1093/ije/dyq231
pubmed: 21345808
pmcid: 3043283
Tillin T, Forouhi NG, McKeigue PM, Chaturvedi N. Southall and Brent REvisited: cohort profile of SABRE, a UK population-based comparison of cardiovascular disease and diabetes in people of European, Indian Asian and African Caribbean origins. Int J Epidemiol. 2012;41:33–42. https://doi.org/10.1093/ije/dyq175 .
doi: 10.1093/ije/dyq175
pubmed: 21044979
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779–9. https://doi.org/10.1371/journal.pmed.1001779 .
doi: 10.1371/journal.pmed.1001779
pubmed: 25826379
pmcid: 4380465
Timpka S, Macdonald-Wallis C, Hughes AD, Chaturvedi N, Franks PW, Lawlor DA, Fraser A. Hypertensive Disorders of Pregnancy and Offspring Cardiac Structure and Function in Adolescence; 2016.
doi: 10.1161/JAHA.116.003906
Cromer BA, Tarnowski KJ. Noncompliance in adolescents: a review. J Dev Behav Pediatr. 1989;10:207–15. https://doi.org/10.1097/00004703-198908000-00010 .
doi: 10.1097/00004703-198908000-00010
pubmed: 2671046
Ghosh AK, Hardy RJ, Francis DP, Chaturvedi N, Pellerin D, Deanfield J, Kuh D, Mayet J, Hughes AD. Medical Research Council National Survey of health and development scientific and data collection T. Midlife blood pressure change and left ventricular mass and remodelling in older age in the 1946 British birth cohort study. Eur Heart J. 2014;35(46):3287–95.
doi: 10.1093/eurheartj/ehu389
pubmed: 25246483
pmcid: 4258225
Al Saikhan L, Park C, Tillin T, Lloyd G, Mayet J, Chaturvedi N, Hughes AD. Relationship between image quality and Bias in 3D echocardiographic measures: data from the SABRE (Southall and Brent Revisited) study. J Am Heart Assoc. 2022;11:e019183–3. https://doi.org/10.1161/JAHA.120.019183 .
doi: 10.1161/JAHA.120.019183
pubmed: 35475343
pmcid: 9238620
Chirinos JA, Segers P, De Buyzere ML, Kronmal RA, Raja MW, De Bacquer D, Claessens T, Gillebert TC, St. John-Sutton M, Rietzschel ER. Left ventricular mass: Allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension (Dallas, Tex 1979). 2010;56:91–8. https://doi.org/10.1161/HYPERTENSIONAHA.110.150250 .
doi: 10.1161/HYPERTENSIONAHA.110.150250
pubmed: 20458004
Petersen SE, Matthews PM, Francis JM, Robson MD, Zemrak F, Boubertakh R, Young AA, Hudson S, Weale P, Garratt S, et al. UK Biobank's cardiovascular magnetic resonance protocol. J Cardiovasc Magn Reson. 2016;18:8–8. https://doi.org/10.1186/s12968-016-0227-4 .
doi: 10.1186/s12968-016-0227-4
pubmed: 26830817
pmcid: 4736703
Bai W, Sinclair M, Tarroni G, Oktay O, Rajchl M, Vaillant G, Lee AM, Aung N, Lukaschuk E, Sanghvi MM, et al. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J Cardiovasc Magn Reson. 2018;20:65–5. https://doi.org/10.1186/s12968-018-0471-x .
doi: 10.1186/s12968-018-0471-x
pubmed: 30217194
pmcid: 6138894
Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, Von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on standardized post-processing. J Cardiovasc Magn Reson. 2020;22:19–9. https://doi.org/10.1186/s12968-020-00610-6 .
doi: 10.1186/s12968-020-00610-6
pubmed: 32160925
pmcid: 7066763
Cerqueira MD, Weissman NJ, Dilsizian JAK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - a statement for healthcare professionals from the cardiac imaging Committee of the Council on clinical cardiology of the American Heart Association. Circulation (New York, NY). 2002;105:539–42. https://doi.org/10.1161/hc0402.102975 .
doi: 10.1161/hc0402.102975
Thanaj M, Mielke J, McGurk KA, Bai W, Savioli N, de Marvao A, Meyer HV, Zeng L, Sohler F, Lumbers RT, et al. Genetic and environmental determinants of diastolic heart function. 2022.
doi: 10.1038/s44161-022-00048-2
Taylor AE, Guthrie PAI, Smith GD, Golding J, Sattar N, Hingorani AD, Deanfield JE, Day INM. IQ, educational attainment, memory and plasma lipids: associations with Apolipoprotein E genotype in 5995 children. Biol Psychiatry. 1969;2011(70):152–8. https://doi.org/10.1016/j.biopsych.2010.10.033 .
doi: 10.1016/j.biopsych.2010.10.033
Rousseau K, Vinall LE, Butterworth SL, Hardy RJ, Holloway J, Wadsworth MEJ, Swallow DM. MUC7 haplotype analysis: results from a longitudinal birth cohort support protective effect of the MUC7 5 allele on respiratory function. Ann Hum Genet. 2006;70:417–27. https://doi.org/10.1111/j.1469-1809.2006.00250.x .
doi: 10.1111/j.1469-1809.2006.00250.x
pubmed: 16759176
Rawle M, Davis D, Bendayan R, Wong A, Kuh D, Richards M. Apolipoprotein-E (ApoE) ε4 and cognitive decline over the adult life course; 2018.
doi: 10.1038/s41398-017-0064-8
Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O’Connell J, et al. The UK biobank resource with deep phenotyping and genomic data. Nature (London). 2018;562:203–9. https://doi.org/10.1038/s41586-018-0579-z .
doi: 10.1038/s41586-018-0579-z
pubmed: 30305743
Townsend P, Beattie A, Phillimore P. Health and deprivation : inequality and the north / Peter Townsend, Peter Phillimore and Alastair Beattie. London: Routledge; 1989.
The R programming language and software. In. 2014:71–117.
Xu H, Li H, Liu J, Zhu D, Wang Z, Chen A, Zhao Q. Meta-analysis of apolipoprotein e gene polymorphism and susceptibility of myocardial infarction. PLoS One. 2014;9:e104608–8. https://doi.org/10.1371/journal.pone.0104608 .
doi: 10.1371/journal.pone.0104608
pubmed: 25111308
pmcid: 4128680
Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, Leon-Latre M, Arbones-Mainar JM. Apolipoprotein E4 association with metabolic syndrome depends on body fatness. ATHEROSCLEROSIS. 2015;245:35–42. https://doi.org/10.1016/j.atherosclerosis.2015.11.029 .
doi: 10.1016/j.atherosclerosis.2015.11.029
pubmed: 26691908
Griffin BA, Walker CG, Jebb SA, Moore C, Frost GS, Goff L, Sanders TAB, Lewis F, Griffin M, Gitau R, et al. APOE4 genotype exerts greater benefit in lowering plasma cholesterol and Apolipoprotein B than wild type (E3/E3), after replacement of dietary saturated fats with low Glycaemic index carbohydrates. NUTRIENTS. 2018;10:1524. https://doi.org/10.3390/nu10101524 .
doi: 10.3390/nu10101524
pubmed: 30336580
pmcid: 6213759
Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Smith GD, Holmes MV. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med. 2020;17:e1003062–2. https://doi.org/10.1371/JOURNAL.PMED.1003062 .
doi: 10.1371/JOURNAL.PMED.1003062
pubmed: 32203549
pmcid: 7089422
Tejedor MT, Garcia-Sobreviela MP, Ledesma M, Arbones-Mainar JM. The apolipoprotein e polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men. PLoS One. 2014;9:e108605–5. https://doi.org/10.1371/journal.pone.0108605 .
doi: 10.1371/journal.pone.0108605
pubmed: 25268647
pmcid: 4182517
Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. INT J OBESITY. 2008;32:1595–605. https://doi.org/10.1038/ijo.2008.143 .
doi: 10.1038/ijo.2008.143
King DL, El-Khoury Coffin L, Maurer MS. Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography. J Am Coll Cardiol. 2002;40:325–9. https://doi.org/10.1016/s0735-1097(02)01944-7 .
doi: 10.1016/s0735-1097(02)01944-7
pubmed: 12106939
Chuang MLMD, Gona PP, Salton CJBA, Yeon SBMDJD, Kissinger KVBSRTMR, Blease SJMPH, Levy DMD, O'Donnell CJMDMPH, Manning WJMD. Usefulness of the left ventricular myocardial contraction fraction in healthy men and women to predict cardiovascular morbidity and mortality. Am J Cardiol. 2012;109:1454–8. https://doi.org/10.1016/j.amjcard.2012.01.357 .
doi: 10.1016/j.amjcard.2012.01.357
pubmed: 22381161
pmcid: 3742100
Rubin J, Steidley DE, Carlsson M, Ong M-L, Maurer MS. Myocardial contraction fraction by M-mode echocardiography is superior to ejection fraction in predicting mortality in transthyretin amyloidosis. J Card Fail. 2018;24:504–11. https://doi.org/10.1016/j.cardfail.2018.07.001 .
doi: 10.1016/j.cardfail.2018.07.001
pubmed: 30010028
pmcid: 6372291
Zhao D, Quill GM, Gilbert K, Wang VY, Houle HC, Legget ME, Ruygrok PN, Doughty RN, Pedrosa J, D'Hooge J, et al. Systematic comparison of left ventricular geometry between 3D-echocardiography and cardiac magnetic resonance imaging. Frontiers in cardiovascular medicine. 2021;8:728205–5. https://doi.org/10.3389/fcvm.2021.728205 .
doi: 10.3389/fcvm.2021.728205
pubmed: 34616783
pmcid: 8488135
Žofková I, Zajíčková K, Hill M, Hořínek A. Apolipoprotein E gene determines serum testosterone and dehydroepiandrosterone levels in postmenopausal women. Eur J Endocrinol. 2002;147:503–6. https://doi.org/10.1530/eje.0.1470503 .
doi: 10.1530/eje.0.1470503
pubmed: 12370113
Ayaz O, Howlett SE. Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms. Biol Sex Differ. 2015;6:9–9. https://doi.org/10.1186/s13293-015-0027-9 .
doi: 10.1186/s13293-015-0027-9
pubmed: 25922656
pmcid: 4411792
Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, Kivimäki M, Singh-Manoux A, Dumurgier J. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study; 2021.
Park J-H, Marwick TH. Use and limitations of E/e' to assess left ventricular filling pressure by echocardiography. Journal of cardiovascular ultrasound. 2011;19:169. https://doi.org/10.4250/jcu.2011.19.4.169 .
doi: 10.4250/jcu.2011.19.4.169
pubmed: 22259658
pmcid: 3259539
Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, Knock DL, Meinders AE, Westendorp RGJ. Total cholesterol and risk of mortality in the oldest old. The Lancet (British edition). 1997;350:1119–23. https://doi.org/10.1016/S0140-6736(97)04430-9 .
doi: 10.1016/S0140-6736(97)04430-9
Glinge C, Lahrouchi N, Jabbari R, Tfelt-Hansen J, Bezzina CR. Genome-wide association studies of cardiac electrical phenotypes. Cardiovasc Res. 2020;116:1620–34. https://doi.org/10.1093/cvr/cvaa144 .
doi: 10.1093/cvr/cvaa144
pubmed: 32428210
pmcid: 7341169
Shah S, Henry A, Roselli C, Lin H, Sveinbjörnsson G, Fatemifar G, Hedman Å, Wilk JB, Morley MP, Chaffin MD, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. 2020.
doi: 10.1038/s41467-019-13690-5
Warren HR, Cabrera CP, Ren M, Kraja AT, Nos F, Loh M, Karaman I, MPS L, Said MA, Farrall M, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49:403–15. https://doi.org/10.1038/ng.3768 .
doi: 10.1038/ng.3768
pubmed: 28135244
pmcid: 5972004
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome medicine. 2020;12:44–4. https://doi.org/10.1186/s13073-020-00742-5 .
doi: 10.1186/s13073-020-00742-5
pubmed: 32423490
pmcid: 7236300